Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review
- PMID: 12012216
- DOI: 10.1007/s00431-002-0953-5
Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review
Abstract
We report the case of a 4-month-old boy presenting with a giant cutaneous haemangioma complicated by Kasabach-Merritt syndrome (KMS) with severe thrombocytopenia. After poor response to corticosteroid therapy and subsequent treatment with interferon alpha-2a, radiotherapy led to tumour regression and resolution of the disseminated intravascular coagulopathy over a 14-month period of follow up. Whereas the various available treatment options are reviewed and discussed in this article, the therapy of choice should be chosen individually.
Conclusion: to date prospective randomised and controlled trials are required to investigate the optimal management of patients with Kasabach-Merritt syndrome.
Comment in
-
Megadose methylprednisolone for Kasabach-Merritt syndrome.Eur J Pediatr. 2003 Jul;162(7-8):562. doi: 10.1007/s00431-002-1142-2. Epub 2003 May 14. Eur J Pediatr. 2003. PMID: 12748852 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
